Psychiatric adverse events during levetiracetam therapy
- PMID: 12963770
- DOI: 10.1212/01.wnl.0000078031.32904.0d
Psychiatric adverse events during levetiracetam therapy
Abstract
The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources